Racura Oncology’s Dual Cancer & Cardio‑Protection Breakthroughs Drive Sydney Biotech
Racura Oncology’s innovative dual‑therapy approach targets metastatic breast cancer & AML while safeguarding heart health, offering breakthrough hope amid volatile biotech markets.
2 minutes to read